Best treatments for aids-related opportunistic infections
9 products may treat aids-related opportunistic infections, spanning FDA drug classes such as cytomegalovirus nucleoside analog dna polymerase inhibitor, nucleoside analog antiviral, sulfone. The current highest-rated option is valganciclovir hydrochloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 9 drugs we list for aids-related opportunistic infections, 7 are available as lower-cost generics, spanning classes such as cytomegalovirus nucleoside analog dna polymerase inhibitor, nucleoside analog antiviral, sulfone. 5 of 9 carry a safety score, from 54 to 72 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for aids-related opportunistic infections — so confirm the right choice with your prescriber.
Top-rated picks for aids-related opportunistic infections: 1. Valganciclovir Hydrochloride · 2. Aczone · 3. Acyclovir Sodium
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Solution | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor | Generic | $56 | View → | |
| 2 | 70/100 | Prescription | Topical | Sulfone | Generic | $24 | View → | |
| 3 | 68/100 | Prescription | Injectable | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor | Generic | $5 | View → | |
| 4 | 66/100 | Prescription | Tablet | Dihydrofolate Reductase Inhibitor Antimalarial | Generic | $4110 | View → | |
| 5 | 54/100 | Prescription | Topical | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor | Generic | $5 | View → | |
| 6 | Not yet rated | Prescription | Capsule | Nucleoside Analog Antifungal | No data | — | View → | |
| 7 | Not yet rated | Prescription | Tablet | Dihydrofolate Reductase Inhibitor Antimalarial | Generic | $4110 | View → | |
| 8 | Not yet rated | Prescription | Solution | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor | Generic | $56 | View → | |
| 9 | Not yet rated | Prescription | Topical | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor | No data | — | View → |
Narrow by drug class
Explore the class hubs: cytomegalovirus nucleoside analog dna polymerase inhibitor · herpes simplex virus nucleoside analog dna polymerase inhibitor · dihydrofolate reductase inhibitor antimalarial
Full ranking · 9 treatments
valganciclovir hydrochloride
Boxed warningPrescriptionFDA-sourced
Valganciclovir Hydrochloride is a cytomegalovirus nucleoside analog dna polymerase inhibitor used to treat Aids-Related Opportunistic Infections, Cytomegalovirus Retinitis.
Pharmacy pays
From ~$37.30/30· 2 formsaczone
PrescriptionFDA-sourced
Aczone (Dapsone) is a sulfone used to treat Dermatitis Herpetiformis, Relapsing Polychondritis, Lepromatous Leprosy, Aids-Related Opportunistic Infections.
Pharmacy pays
From ~$15.47/30· 4 formsacyclovir sodium
PrescriptionFDA-sourced
Acyclovir Sodium is a herpes simplex virus nucleoside analog dna polymerase inhibitor used to treat Chickenpox, Herpes Genitalis, Herpes Labialis, Herpes Zoster Ophthalmicus.
Pharmacy pays
From ~$2.22/30· 6 formspyrimethamine
PrescriptionFDA-sourced
Pyrimethamine is a dihydrofolate reductase inhibitor antimalarial used to treat Toxoplasmosis, Falciparum Malaria, Aids-Related Opportunistic Infections.
Pharmacy pays
~$4110.26 /30
acyclovir
PrescriptionFDA-sourced
Acyclovir is a herpes simplex virus nucleoside analog dna polymerase inhibitor used to treat Chickenpox, Herpes Genitalis, Herpes Labialis, Herpes Zoster Ophthalmicus.
Pharmacy pays
From ~$2.22/30· 6 formsancobon
Boxed warningPrescriptionFDA-sourced
Ancobon (Flucytosine) is a nucleoside analog antifungal used to treat Aspergillosis, Candidiasis, Chromoblastomycosis, Cryptococcal Meningitis.
Frequently asked
- What treats aids-related opportunistic infections?
- Our catalog lists 9 products that may treat aids-related opportunistic infections, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is valganciclovir hydrochloride.
- What is the best-rated treatment for aids-related opportunistic infections?
- By our independent recall-safety rating — not an efficacy measure — valganciclovir hydrochloride ranks highest among the products we list for aids-related opportunistic infections. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat aids-related opportunistic infections?
- Treatments for aids-related opportunistic infections span FDA drug classes including cytomegalovirus nucleoside analog dna polymerase inhibitor, nucleoside analog antiviral, sulfone, herpes simplex virus nucleoside analog dna polymerase inhibitor, herpes zoster virus nucleoside analog dna polymerase inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status